Brief: Adma Biologics Announces Third Quarter 2022 Financial Results

ADMA Biologics

09/11/2022 21:58

Nov 9 (Reuters) - Adma Biologics Inc  ADMA.O :
    * ADMA BIOLOGICS ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * Q3 REVENUE ROSE 99 PERCENT TO $41.1 MILLION
    * RAISING FY 2022 TOTAL REVENUE GUIDANCE TO $145 MILLION
FROM $130
MILLION PREVIOUSLY
    * GROSS PROFIT GROWTH AND NARROWING NET LOSSES EXPECTED INTO
2023
    * CONSOLIDATED NET LOSS FOR QUARTER ENDED SEPTEMBER 30, 2022
WAS
$14.9 MILLION, OR $0.08 PER BASIC AND DILUTED SHARE
    * Q3 EARNINGS PER SHARE VIEW $-0.08 -- REFINITIV IBES DATA
    * Q3 REVENUE VIEW $34.5 MILLION -- REFINITIV IBES DATA
    * FY2022 REVENUE VIEW $134.4 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3zPtr 
Further company coverage:  ADMA.O 
 ((Reuters.Briefs@thomsonreuters.com;))